Edgewise Therapeutics logo

Edgewise Therapeutics share price today

(EWTX)

Edgewise Therapeutics share price is $30.78 & ₹2,615.56 as on 21 Dec 2024, 2.30 'hrs' IST

$30.78

-0.02

(-0.06%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Edgewise Therapeutics share price in Dollar and Rupees. Guide to invest in Edgewise Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Edgewise Therapeutics. Get details on the Indian mutual funds that are investing in Edgewise Therapeutics. Get Analyst recommendations and forecasts along with all the Edgewise Therapeutics's financials.

Edgewise Therapeutics share price movements

  • Today's Low: $30.07
    Today's High: $32.61

    Day's Volatility :7.8%

  • 52 Weeks Low: $9.00
    52 Weeks High: $38.12

    52 Weeks Volatility :76.39%

Edgewise Therapeutics Returns

PeriodEdgewise Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
16.19%
-11.1%
0.0%
6 Months
84.2%
-6.0%
0.0%
1 Year
223.32%
2.7%
0.0%
3 Years
92.01%
0.6%
-19.7%

Edgewise Therapeutics Key Statistics

in dollars & INR

Previous Close
$30.8
Open
$30.54
Today's High
$32.61
Today's Low
$30.065
Market Capitalization
$2.9B
Today's Volume
$1.1M
52 Week High
$38.12
52 Week Low
$9.0
Revenue TTM
$0.0
EBITDA
$-145.2M
Earnings Per Share (EPS)
$-1.5
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-31.9%

How to invest in Edgewise Therapeutics from India?

It is very easy for Indian residents to invest directly in Edgewise Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Edgewise Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Edgewise Therapeutics or EWTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Edgewise Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Edgewise Therapeutics shares which would translate to 0.028 fractional shares of Edgewise Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Edgewise Therapeutics, in just a few clicks!

Returns in Edgewise Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Edgewise Therapeutics investment value today

Current value as on today

₹3,25,515

Returns

₹2,25,515

(+225.52%)

Returns from Edgewise Therapeutics Stock

₹2,23,319 (+223.32%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Edgewise Therapeutics

-50%

Period: Sep 22, 2024 to Dec 21, 2024. Change in 30 Days versus previous period

Search volume for Edgewise Therapeutics on INDmoney from India has reduced in the last 30 days as on Dec 22, 2024. -50% less investors are searching Edgewise Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Edgewise Therapeutics

  • Orbimed Advisors, LLC

    15.86%

  • RA Capital Management, LLC

    9.41%

  • BlackRock Inc

    6.35%

  • Baker Bros Advisors LP

    6.17%

  • Novo A/S

    5.86%

  • HHG PLC

    4.81%

Analyst Recommendation on Edgewise Therapeutics

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Edgewise Therapeutics(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
10
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Edgewise Therapeutics

What analysts predicted

Upside of 60.59%

Current:

$30.78

Target:

$49.43

Insights on Edgewise Therapeutics

  • Price Movement

    In the last 7 days, EWTX stock has moved up by 11.4%

Edgewise Therapeutics Technicals Summary

Sell

Neutral

Buy

Edgewise Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Edgewise Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Edgewise Therapeutics Inc
-4.41%
84.2%
223.32%
92.01%
7.7%
Regeneron Pharmaceuticals, Inc.
-5.73%
-34.03%
-17.38%
12.23%
86.41%
Biontech Se
4.48%
30.56%
7.97%
-55.71%
237.85%
Alnylam Pharmaceuticals, Inc.
-0.55%
10.11%
28.37%
26.29%
108.55%
Vertex Pharmaceuticals Incorporated
-11.79%
-16.36%
-2.55%
77.79%
80.12%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Edgewise Therapeutics Inc
3.7
NA
NA
-1.5
-0.32
-0.22
NA
5.18
Regeneron Pharmaceuticals, Inc.
17.51
17.51
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.55
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Edgewise Therapeutics Inc
Buy
$2.9B
7.7%
3.7
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$77.8B
86.41%
17.51
33.61%
Biontech Se
Buy
$26.7B
237.85%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.8B
108.55%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$102.1B
80.12%
32.84
-4.51%

About Edgewise Therapeutics

edgewise therapeutics is a biotechnology company focused on developing novel therapies for diseases involving skeletal muscle. the company is headquartered in boulder, co and received its series a financing from orbimed.
Organization
Edgewise Therapeutics
Employees
108
CEO
Dr. Peter A. Thompson FACP, M.D.
Industry
Healthcare

Management People of Edgewise Therapeutics

NameTitle
Dr. Peter A. Thompson FACP, M.D.
Co-Founder & Independent Chairman
Dr. Kevin Koch Ph.D.
President, CEO & Director
Dr. Badreddin Edris Ph.D.
Co-Founder & Independent Director
Dr. Behrad Derakhshan Ph.D.
Chief Business Officer
Dr. Joanne M. Donovan M.D., Ph.D.
Chief Medical Officer
Dr. Alan J. Russell Ph.D.
Co-Founder, Chief Scientific Officer & Director
Mr. R. Michael Carruthers
Chief Financial Officer
Mr. John R. Moore J.D.
General Counsel
Dr. Marc Semigran M.D.
Chief Development Officer

Important FAQs about investing in Edgewise Therapeutics from India :

What is Edgewise Therapeutics share price today?

Edgewise Therapeutics share price today stands at $30.78, Open: $30.54 ; Previous Close: $30.80 ; High: $32.61 ; Low: $30.07 ; 52 Week High: $38.12 ; 52 Week Low: $9.00. The stock opens at $30.54, after a previous close of $30.80. The stock reached a daily high of $32.61 and a low of $30.07, with a 52-week high of $38.12 and a 52-week low of $9.00.

Can Indians buy Edgewise Therapeutics shares?

Yes, Indians can invest in the Edgewise Therapeutics (EWTX) from India.

With INDmoney, you can buy Edgewise Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Edgewise Therapeutics at zero transaction cost.

How can I buy Edgewise Therapeutics shares from India?

It is very easy to buy Edgewise Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Edgewise Therapeutics be purchased?

Yes, you can buy fractional shares of Edgewise Therapeutics with INDmoney app.

What are the documents required to start investing in Edgewise Therapeutics stocks?

To start investing in Edgewise Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Edgewise Therapeutics

Today’s highest price of Edgewise Therapeutics (EWTX) is $32.61.

Today’s lowest price of Edgewise Therapeutics (EWTX) is $30.07.

What is today's market capitalisation of Edgewise Therapeutics

Today's market capitalisation of Edgewise Therapeutics EWTX is 2.9B

What is the 52 Week High and Low Range of Edgewise Therapeutics

  • 52 Week High

    $38.12

  • 52 Week Low

    $9.00

What are the historical returns of Edgewise Therapeutics?

  • 1 Month Returns

    -4.41%

  • 3 Months Returns

    84.2%

  • 1 Year Returns

    223.32%

  • 5 Years Returns

    7.7%

Who is the Chief Executive Officer (CEO) of Edgewise Therapeutics

Dr. Peter A. Thompson FACP, M.D. is the current Chief Executive Officer (CEO) of Edgewise Therapeutics.